Package 58468-0220-2

{"route": ["ORAL"], "spl_id": "e71b0b39-5a29-4e38-8500-55b6d1f48543", "openfda": {"nui": ["N0000175783", "N0000020019", "N0000185503", "N0000182137"], "unii": ["DR40J4WA67"], "rxcui": ["1547225", "1547231"], "spl_set_id": ["819f828a-b888-4e46-83fc-94d774a28a83"], "pharm_class_epc": ["Glucosylceramide Synthase Inhibitor [EPC]"], "pharm_class_moa": ["Glucosylceramide Synthase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Genzyme Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (58468-0220-1)  / 14 CAPSULE in 1 BLISTER PACK", "package_ndc": "58468-0220-1", "marketing_start_date": "20140903"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (58468-0220-2)  / 14 CAPSULE in 1 BLISTER PACK", "package_ndc": "58468-0220-2", "marketing_start_date": "20140903"}], "brand_name": "Cerdelga", "product_id": "58468-0220_e71b0b39-5a29-4e38-8500-55b6d1f48543", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Glucosylceramide Synthase Inhibitor [EPC]", "Glucosylceramide Synthase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "58468-0220", "generic_name": "eliglustat", "labeler_name": "Genzyme Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cerdelga", "active_ingredients": [{"name": "ELIGLUSTAT", "strength": "84 mg/1"}], "application_number": "NDA205494", "marketing_category": "NDA", "marketing_start_date": "20140903", "listing_expiration_date": "20261231"}